CL
Claritas Pharmaceuticals, Inc.
CLAZF · OTC
$0.00 +0.00% (+$0.00)
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
0 /100
Unstable Beta 2.12x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CLAZF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Farrell
Employees
3
Headquarters
San Rafael
Evenimente viitoare
30 NOV.
Earnings
Upcoming earnings report